INVOKANA
INVOKANA
Approved
DIN Number
02425491
Drug Class
Human
Market Date
May 28, 2014
Company
HC
Janssen Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02425491
AIG Number0155670002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A10BK02 CANAGLIFLOZIN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:20.18
Health Canada Classification
ACTIVE INGREDIENTS (1)
CANAGLIFLOZINActive
Strength: 300 MG
Monograph: CANAGLIFLOZIN